HYTERA
28.3.2022 08:02:10 CEST | Business Wire | Press release
Hytera (SZSE: 002583), the global leading provider of professional communications equipment and solutions, is delighted to announce the launch of its next generation H Series of DMR terminals, designed to meet and exceed the increasingly complex and demanding communication challenges facing public safety, energy, transportation, utilities, commercial and other industry verticals.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220327005001/en/
Built for Customer Success
The newly developed hardware platform and software architecture delivers improved radio performance and optimises the user experience to provide more intuitive, practical, and easy to use functionality. This allows users to focus on the task in hand and provide better, safer and more efficient outcomes for the organisations and communities they serve.
Lighter, Slimmer and More Powerful
The new hand portables comprise the HP7 Series (HP78X/HP70X) and the HP6 Series (HP68X/HP60X) radios. They are more compact, lighter and deliver increased battery capacity and battery life. The radios provide enhanced audio clarity and loudness thanks to a combination of high-performance speakers and DSP algorithm, while embedded AI noise cancellation makes the audio even clearer.
Impressive New Features
Other innovations include using the vibration of the speaker to expel water through a specially designed cavity to ensure clear audio even in torrential weather. Direct mode communication range is extended by 25% in open environments, while signal quality is improved at the edge of the network when in trunking mode.
The HM78X mobile radio delivers similar performance enhancements as the portable terminals. New highlights include an optimised control head-mounting solution that supports flexible deployment options. The inclusion of an Ethernet port allows the radio to function as a gateway for narrowband networking, while also supporting the easy addition of new features from third-party companies and platforms.
The HR106X compact digital repeater completes the latest line-up. Despite being half the size of its predecessor, Hytera has managed to integrate a telephone gateway, router and power adapter inside this versatile repeater to provide an all-in-one solution.
Hytera users depend on the ingenuity and advancement that only Hytera can deliver, to help them carry out the most demanding tasks in challenging environments. Hytera’s H Series solutions are designed for optimum performance that is more powerful, more capable and even easier to use than ever before, enabling users to respond and achieve.
Hytera held its global online launch event on March 24th during which it introduced and demonstrated the brand-new H Series and business radio series AP/BP. It also shared insights on PMR industry trends and expertise on professional communications at the event.
Watch the recorded event here: https://bit.ly/3urgQfg
View source version on businesswire.com: https://www.businesswire.com/news/home/20220327005001/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release
FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 16:13:00 CEST | Press release
In a head-to-head benchmark, a leading general-purpose LLM was confidently wrong 35% of the time on regulatory dates. Archer Evolv™ shipped zero errors. For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and mo
Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 16:08:00 CEST | Press release
Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d
Interactive Brokers Expands Access to Korean Equities with Launch of Nextrade ATS30.6.2026 16:00:00 CEST | Press release
IB SmartRouting℠ Routes Orders to the Best Available Price Between KRX and Nextrade Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced the launch of select Korean equities through Nextrade, South Korea's first Alternative Trading System (ATS). The addition of Nextrade builds on Interactive Brokers' earlier launch of the Korea Exchange (KRX), through which it became the first major US-based broker to provide global investors with direct access to Korean equities. Clients trading on Nextrade benefit from significantly extended trading hours and access to additional liquidity. Interactive Brokers has enabled IB SmartRouting℠ across both the Korea Exchange (KRX) and Nextrade, automatically routing orders to the venue offering the best price. This helps clients achieve best execution while providing greater flexibility and more opportunities to participate in one of Asia's most dynamic equity markets. Korea's equity market ranks among the top global exchanges by
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom